IN VIVO LONG TERM EVALUATION OF TRANSCUTANEOUS ENERGY TRANSMISSION FOR TATALLY IMPLANTABLE ARTIFITIAL HEART

ASAIO Journal ◽  
2000 ◽  
Vol 46 (2) ◽  
pp. 170 ◽  
Author(s):  
Y. Kakuta ◽  
E. Tatsumi ◽  
Y. Taenaka ◽  
K. Uesho ◽  
A. Homma ◽  
...  
2021 ◽  
pp. 100172
Author(s):  
Chen Lai ◽  
Shu-Jiang Zhang ◽  
Xuan-Chen Chen ◽  
Li-Yuan Sheng ◽  
Tian-Wei Qi ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Eduardo Romero ◽  
Alfonso Martínez ◽  
Marta Oteo ◽  
Marta Ibañez ◽  
Mirentxu Santos ◽  
...  

AbstractRadionuclide generator systems can routinely provide radionuclides on demand such as 68Ga produced by a 68Ge/68Ga generator without the availability of an on-site accelerator or a research reactor. Thus, in this work nano-SnO2 was used to develop a new 68Ge/68Ga generator which was evaluated over a period of 17 months and 305 elution cycles. The elution yield was 91.1 ± 1.8% in the first 7 mL (1 M HCl as eluent) when the generator was new and then it decreased with time and use to 73.8 ± 1.9%. Around 80% of the elutable 68Ga activity was obtained in 1 mL and the 68Ge content in the eluate did not exceed 1 × 10–4% over the investigation period when it was eluted regularly. The described generator provided adequate results for radiolabelling of DOTA-TOC with direct use of eluate. In addition, [68Ga]Ga-DOTA-TOC was tested satisfactorily for in vivo tumor detection by microPET/CT imaging in a lung cancer mouse model.


2012 ◽  
Vol 195-196 ◽  
pp. 1169-1174
Author(s):  
Liang Yu Bai ◽  
Yu Zheng ◽  
Hou Jun Tang

Transcutaneous energy transmission (TET) systems are designed to deliver power from an in vitro primary power source to in vivo implantable secondary over relatively large air gaps via magnetic coupling. This paper proposes an optimization method with given output power to meet different practical application. The transmission efficiency is the objective function; primary and secondary coils are design variables; constraints are based on bifurcation phenomenon and components peak over-voltage and peak withstand current. We have used MATLAB/ SIMULINK to verify the analytical results.


2017 ◽  
Vol 13 (3) ◽  
pp. 272-279 ◽  
Author(s):  
Athanasios Peppas ◽  
Ariel Furer ◽  
Jon Wilson ◽  
GengHua Yi ◽  
Yanping Cheng ◽  
...  

ASAIO Journal ◽  
1993 ◽  
Vol 39 (3) ◽  
pp. M373-M380 ◽  
Author(s):  
Eisuke Tatsumi ◽  
Pratap S. Khanwilkar ◽  
John R. Rowles ◽  
Bang Y. Chiang ◽  
Gregory L. Burns ◽  
...  

2013 ◽  
Vol 62 (18) ◽  
pp. B249
Author(s):  
Athanasios Peppas ◽  
Jon Wilson ◽  
Yanping Cheng ◽  
Christopher Seguin ◽  
Masahiko Shibuya ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-9 ◽  
Author(s):  
Pilar Valderrama ◽  
Thomas G. Wilson Jr

Purpose. Peri-implantitis is one of the major causes of implant failure. The detoxification of the implant surface is necessary to obtain reosseointegration. The aim of this review was to summarize in vitro and in vivo studies as well as clinical trials that have evaluated surgical approaches for detoxification of the implant body surfaces.Materials and Methods. A literature search was conducted using MEDLINE (PubMed) from 1966 to 2013. The outcome variables were the ability of the therapeutic method to eliminate the biofilm and endotoxins from the implant surface, the changes in clinical parameters, radiographic bone fill, and histological reosseointegration.Results. From 574 articles found, 76 were analyzed. The findings, advantages, and disadvantages of using mechanical, chemical methods and lasers are discussed.Conclusions. Complete elimination of the biofilms is difficult to achieve. All therapies induce changes of the chemical and physical properties of the implant surface. Partial reosseointegration after detoxification has been reported in animals. Combination protocols for surgical treatment of peri-implantitis in humans have shown some positive clinical and radiographic results, but long-term evaluation to evaluate the validity and reliability of the techniques is needed.


Sign in / Sign up

Export Citation Format

Share Document